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SUMMARY – Spontaneous resolution of nonfunctioning pituitary adenoma after hemorrhagic 
apoplexy is a rare clinical entity of unknown etiology and is defined as disappearance of a tumor with-
out any specific treatment. Here we present a 54-year-old male patient who presented with acute 
onset of severe headache, vomiting, photophobia, and sonophobia. He was referred to brain computed 
tomography, which showed a 16x12x16 mm tumor mass located in the sellar region with signs of 
hemorrhage. Endocrinologic evaluation was consistent with under-function of pituitary gonadotropic 
cells. Magnetic resonance imaging (MRI) performed ten days later was consistent with hemorrhagic 
apoplexy of the pituitary adenoma. The patient’s symptoms resolved after conservative treatment with 
dexamethasone, but he was scheduled for elective pituitary surgery. Preoperative MRI was performed 
one month after the first one and disclosed normal pituitary gland without any signs of adenoma. Our 
case is remarkable due to the fact that spontaneous remission of pituitary adenoma occurred within 
the first month, which is the shortest interval reported to date. Our case highlights the importance of 
conservative therapy as the first-line treatment for pituitary apoplexy in the absence of neurological 
impairment, since spontaneous remission may occur in a short time interval.
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Introduction
Pituitary gland, also known as hypophysis, is a 
gland located at the skull base in the area called sella 
turcica1. Pituitary adenomas are the most common tu-
mors of the sellar region and they grow from adenohy-
pophysis cells. They account for 15% of all intracranial 
tumors. Depending on the size, they are divided 
into microadenomas (<10 mm) and macroadenomas 
(>10 mm). With rapid improvement of new neurora-
diological diagnostic procedures and ever greater pow-
er, precision and availability of magnetic resonance 
imaging (MRI) machines, it has become clear that 
their incidence is much higher than assumed. Their 
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prevalence is estimated to 0.1% in the general popula-
tion2, while autopsy series have reported a prevalence 
of 25%3. Pituitary adenomas are referred to as inciden-
talomas if they are an incidental finding in asymptom-
atic patients3. Pituitary apoplexy (PA) is a rare clinical 
syndrome that occurs due to ischemic or hemorrhagic 
necrosis of the pituitary gland, and it is found as a 
complication in 2%-12% of pituitary tumors, especial-
ly nonfunctioning adenomas4. Most of these patients 
have PA as an initial manifestation of the underlying 
pituitary tumor5,6. It is more frequent in men during 
the 5th and 6th decades of life7,8. Patients with symp-
tomatic PA complain of sudden and intense headache, 
rapid and dramatic visual impairment, vomiting, and, 
in the most severe cases, impaired consciousness9. 
Headache is often retro-orbital or frontal, intense and 
lancinating, and insensitive to analgesics10.
Apoplexy is likely to induce spontaneous disap-
pearance of those tumors. After hemorrhage and con-
sequent necrosis, pituitary adenomas may sometimes 
be reabsorbed by the healthy tissue and vasculature in 
the surrounding area, which results in spontaneous ad-
enoma resolution11.
To date, only 13 cases of nonfunctioning pituitary 
adenomas with spontaneous resolution have been re-
ported in the world’s literature12. The shortest time in-
terval during which reduction in tumor volume oc-
curred was 27 days13, whereas the shortest period of 
complete spontaneous resolution reported so far was 
45 days14. In this case report, we describe complete 
spontaneous tumor resolution within 28 days.
Case Report
A 54-year-old man presented to the emergency 
neurological department with acute onset of severe 
headache in the frontal area with pulsative character, 
associated with vomiting, photophobia and sonopho-
bia. The patient had been taking paracetamol in the 
last six hours, without any relief of symptoms. His 
medical history was unremarkable.
After general and neurological examination, which 
were unremarkable, the patient was referred to emer-
gency brain computed tomography (CT) with con-
trast, which showed a 16x12x16 mm mass of heteroge-
neous density and a central hyperdense area located in 
the sellar and suprasellar region, consistent with pitu-
itary macroadenoma with signs of hemorrhage. An ac-
cidental finding of a 12x9 mm meningioma in the 
parasagittal left frontal lobe was also reported. Based 
on the clinical and radiological findings, the patient 
was diagnosed with hemorrhagic PA. He was admit-
ted to the hospital and antiedematous therapy with 24 
mg of dexamethasone was initiated. Laboratory evalu-
ation showed normal complete blood count, biochem-
ical parameters and tumor markers. Endocrinological 
evaluation disclosed normal function of pituitary so-
matotropic, lactotropic and thyrotropic cells. Morning 
cortisol was suppressed due to antiedematous therapy, 
whereas the remaining findings were consistent with 
central hypogonadism: luteinizing hormone 0.658 
IU/L (normal, 1.7-8.6 IU/L), follicle-stimulating hor-
mone 1.35 IU/L (normal, 1.5-12.4 IU/L), total testos-
terone 1.010 nmol/L (normal, 6.68-25.7 nmol/L), 
sex hormone binding globulin 90.09 nmol/L (normal, 
14.5-48.4 nmol/L), and free testosterone 0.009 nmol/L 
(normal, 0.204-0.637 nmol/L). The patient’s symp-
toms resolved after conservative treatment with dexa-
methasone within two days.
Ten days of admission, magnetic resonance imag-
ing (MRI) was performed to show a 16x13x18 mm 
mass with high signal intensity on T1-weighted im-
ages and heterogeneous post-contrast imbibition lo-
cated in the sellar and suprasellar region. The mass 
obliterated the suprasellar cistern and spread to the 
optic chiasm without compressing it, caudally thinned 
and remodeled the bottom of the sella turcica and dor-
sally also the dorsum of the sella turcica, while the cav-
ernous sinuses appeared free, consistent with pituitary 
macroadenoma with signs of hemorrhage (Fig. 1). 
Goldmann perimetry results were normal. The patient 
was discharged from the hospital with a recommenda-
tion to seek consultation at the national reference cen-
ter for pituitary tumors for preoperative preparation 
and operative treatment.
At the national center, preoperative endocrinologi-
cal and neuroradiological evaluations were performed. 
Low levels of total testosterone 4.1 nmol/L (normal, 
6.68-25.7 nmol/L), suboptimal cortisol response dur-
ing low-dose Synacthen test (cortisol I 286 nmol/L, 
cortisol II 480 nmol/L, cortisol III 337 nmol/L) and 
low normal T4 77 nmol/L (normal, 76-157 nmol/L) 
and thyroid-stimulating hormone 1.369 mIU/L (nor-
mal, 0.34-5.60 mIU/L) were found. Preoperative 
MRI, which was performed exactly 28 days after the 
first one, showed the pituitary of appropriate dimen-
L. Komić et al. Spontaneous resolution of pituitary adenoma
Acta Clin Croat, Vol. 60, No. 2, 2021 319
sions for age, without any signs of adenoma, discretely 
raised right half of the adenohypophysis with the vis-
ible dominant high intensity signal on T1-weighted 
images, size 7x2x6 mm, with mixed signal intensity on 
T2-weighted images. The pituitary gland showed rela-
tively homogeneous imbibition on the post-contrast 
images. These findings could be explained with the re-
maining hemorrhagic area in the right half of the ad-
enohypophysis without any signs of adenoma. Optic 
chiasm had normal appearance (Fig. 2). Hence, MRI 
showed no signs of pituitary tumor and it was consis-
tent with spontaneous resolution of nonfunctioning 
pituitary adenoma. The patient was discharged from 
the hospital without surgical intervention and with 
recommendation to take replacement therapy (hydro-
cortisone 5 mg in the morning and 2.5 mg at 5.00 PM 
per os, levothyroxine sodium 25 mcg in the morning 
per os and testosterone 50 mg topically). Follow-up ap-
pointment was scheduled in 3 months.
At the 3-month follow-up, the patient stated that 
he had not taken the recommended replacement ther-
apy. Endocrinological re-evaluation was consistent 
with normal function of all pituitary cells. Repeated 
MRI showed a distinctly thinned pituitary gland lean-
ing broadly against the bottom of the sella, consistent 
with the partially empty sella, without any signs of ad-
enoma. The right half of the adenohypophysis had a 
slightly inhomogeneous structure and the pituitary 
stalk was minimally slanted to the left with normal 
thickness and post-contrast imbibition. Optic chiasm 
and cavernous sinuses had normal appearance (Fig. 3). 
The patient was in good general condition and dis-
charged from the hospital without any replacement 
Fig. 4. Coronal T1-weighted magnetic resonance image 
obtained at 12-month follow-up demonstrating the 
partially empty sella without any signs of adenoma.
Fig. 1. Coronal T1-weighted magnetic resonance image 
demonstrating a 16x13x18 mm mass located in the sellar 
and suprasellar region.
Fig. 2. Coronal T1-weighted preoperative magnetic 
resonance image performed after 28 days demonstrating 
pituitary gland of appropriate dimensions for age, 
without any signs of adenoma and with the remaining 
hemorrhagic area in the right half of the adenohypophysis.
Fig. 3. Coronal T1-weighted magnetic resonance  
image obtained at 3-month follow-up  
demonstrating the partially empty sella  
without any signs of adenoma.
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therapy, and scheduled for re-evaluation in one-year 
period.
At the 12-month follow-up, endocrinological re-
evaluation was again consistent with normal function 
of all pituitary cells. MRI also remained unchanged 
throughout the follow-up period and was consistent 
with the partially empty sella, without any signs of ad-
enoma (Fig. 4).
Discussion
To our knowledge, we are the first to describe a case 
of complete spontaneous resolution of a nonfunction-
ing pituitary adenoma within the first month (28 
days), while the shortest period described so far in the 
literature was 45 days14. Spontaneous tumor resolution 
in this case was most likely because of infarction, hem-
orrhage and necrosis. Spontaneous resolution of non-
functioning pituitary adenoma is an uncommon phe-
nomenon. To the best of our knowledge, 13 cases of 
spontaneous resolution of nonfunctioning adenomas 
have been reported12.
In addition to complete tumor resolution in most 
cases, Eichberg et al. found that 23% of cases resulted 
in the development of empty sella and hypopituita-
rism, 8% in decreased tumor size but still radiographi-
cally visible, and 8% in tumor regrowth after resolu-
tion12. The pathophysiology underlying spontaneous 
resolution after apoplexy is not fully understood so 
far15. After hemorrhage and consequent necrosis, pitu-
itary adenomas sometimes may be reabsorbed by the 
healthy tissue and vasculature in the surrounding area, 
which results in spontaneous adenoma resolution11. 
The mechanism of PA also remains unclear. In com-
parison to the normal pituitary gland, blood supply to 
pituitary adenomas is diminished and there is also evi-
dence that pituitary adenomas have impaired angio-
genesis and reduced vessel density16. Consequently, 
one of the proposed mechanisms of PA is that the 
rapid tumor growth may outstrip arterial blood supply 
and lead to ischemia17. Alternatively, the mass effect of 
the growing tumor may compress the pituitary vessels, 
thus compromising blood flow to a tumor with intrin-
sically poor vascularity and leading to ischemia and 
hemorrhagic infarction18. Although it can occur with-
out any risk factors, many patients with PA have some 
precipitating factors such as systemic hypertension, 
major surgery, coagulopathies, anticoagulation, throm-
bolytic and antiplatelet therapy, estrogen therapy, 
pregnancy, postpartum state, radiation therapy, or head 
trauma19-21.
Although there is a universal consensus that, once 
PA is diagnosed, high-dose corticosteroids should be 
administered immediately along with supportive mea-
sures to ensure hemodynamic stability, further man-
agement of PA is still a matter of debate. In patients 
with acute and severe forms of PA, which include sig-
nificant neuro-ophthalmic impairment or altered level 
of consciousness, transsphenoidal surgical decompres-
sion is considered the gold standard technique, where-
as in patients without visual acuity or field defects and 
with normal consciousness some adopt conservative 
approach18. One of the first to suggest conservative ap-
proach were Pelkonen et al. in 1978, whereas Maccag-
nan et al. report that conservative management was 
possible in 60% of patients with a similar post-treat-
ment prevalence of pituitary hormone deficiency and 
incidence of tumor recurrence in patients who under-
went surgical or conservative treatment22,23. Kirigin 
Biloš et al. postulate that conservative management of 
PA may be a proper alternative to surgery, although it 
is challenging to assess which patients can be safely 
monitored versus those at risk of negative outcomes 
because the risk factors for tumor progression or recur-
rent apoplexy remain unknown24.
In our case, the patient presented with acute onset 
of severe headache associated with vomiting, photo-
phobia and sonophobia. The patient’s symptoms re-
solved after conservative treatment with dexametha-
sone but he was scheduled for elective pituitary sur-
gery, which was not performed because preoperative 
MRI disclosed normal pituitary gland without any 
signs of adenoma. Our case emphasizes the impor-
tance of analyzing all preoperative cranial imaging 
prior to surgery and highlights the importance of con-
servative therapy as the first-line treatment for PA in 
the absence of neurological impairment, since sponta-
neous remission may occur in short time interval. In 
addition, we strongly recommend re-evaluation of pi-
tuitary function and MRI by the multidisciplinary pi-
tuitary teams to surveil for possible tumor recurrence.
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Sažetak
SPONTANI NESTANAK NEFUNKCIONALNOG ADENOMA HIPOFIZE U MJESEC DANA:  
PRIKAZ SLUČAJA
L. Komić, I. Kruljac, G. Mirošević, P. Gaćina, H. I. Pećina, V. Čerina, D. Gajski, K. Blaslov, K. Rotim i M. Vrkljan
Spontana regresija nefunkcionalnog adenoma hipofize nakon hemoragijske apopleksije je iznimno rijedak klinički entitet 
nepoznate etiologije, a definiran je kao nestanak tumora bez primijenjenog liječenja. Naš 54-godišnji bolesnik prezentirao se 
izrazito jakom, naglo nastalom glavoboljom, povraćanjem, fotofobijom i sonofobijom. Bolesnik je upućen na hitnu kompju-
toriziranu tomografiju mozga koja je pokazala selarnu tumorsku tvorbu 16x12x16 mm sa zonom krvarenja. Endokrinološki 
nalazi upućivali su na disfunkciju gonadotropnih stanica hipofize. Nakon deset dana učinjena je magnetska rezonanca (MR) 
kojom je potvrđena hemoragijska apopleksija adenoma hipofize. Simptomi su se povukli nakon primijenjene konzervativne 
terapije deksametazonom, ali je bolesnik zakazan za kiruršku resekciju adenoma. Prijeoperacijski MR učinjen mjesec dana 
nakon prvoga pokazao je normalnu hipofizu bez znakova adenoma. Posebnost našega slučaja je vrijeme manje od mjesec 
dana u kojem se dogodila spontana remisija, što je najkraće dosad opisano vrijeme u svjetskoj literaturi. Naš slučaj naglašava 
važnost konzervativne terapije kao prve terapijske linije kod apopleksije adenoma hipofize u bolesnika bez neuroloških 
 deficita i to upravo zbog činjenice što je spontana remisija moguća u kratkom vremenskom intervalu nakon pojave samih 
simptoma.
Ključne riječi: Tumori hipofize; Apopleksija hipofize; Adenom; Sindrom prazne sele; Regresija tumora, spontana; Remisija, 
spontana
